FULC vs L · $427.0M cap vs P/E 14, rev $18.45B
Fulcrum Therapeutics Inc (FULC) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
FULC does not have a complete income-statement cache yet.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
FULC currently screens at market cap $427.0M. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the FULC and L stock pages for the full models.
Not investment advice.